Surface tension versus time of the MHS solution (50 mM) and LNC dispersion containing 50 mM MHS as determined by drop tensiometry. by Celia R. A. Mouzouvi (4347937)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

<i>btuE</i> expression results in decreased intracellular ROS. by Felipe A. Arenas (23050)

<i>E. faecalis</i> metabolism decreases after exposure to bilirubin. by Christopher L. Nobles (437464)

Predictive values of IC₅₀ in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC₅₀ in mM (FFAs) and decreasing blood glucose level. by Elena V. Fedorova (603922)

“…<p>Predictive values of IC₅₀ in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC₅₀ in mM (FFAs) and decreasing blood glucose level.…”

Chemical Inhibition of eEF1A-1 Peptide Elongation Activity Decreases Palmitate-Induced Cell Death. by Alexandra M. Stoianov (759321)

eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

“…HEK293 eNOS control, *, <i>p</i> < 0.01). 50ng/mL VEGF caused further decrease of cell viability in eNOS overexpressing HEK293 cells treated with 10mM DAHP (VEGF plus DAHP vs. …”

Downregulation of G9a induces autophagy and decreases tumorigenicity in neuroblastoma cells. by Xiao-Xue Ke (626989)

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

EBP is involved in the kE-induced GM₃ levels decrease. by Anthony Rusciani (359756)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…When tumors reached an average of 150 mm³, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”

GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

“…(<b>D,E</b>) The channel open probability was evaluated by measuring the degree of MTSEA (200 μM) potentiation using TEVC recordings from <i>Xenopus</i> oocytes expressing the WT GluN2A (<i>left panel</i>) or the mutant GluN2A(D731N) (<i>right panel</i>) coexpressed with GluN1(A652C) at a holding potential of -40 mV in presence of EC₅₀ concentrations of glutamate with saturating concentration (100 μM) of glycine (open bar) and 0.2 mM MTSEA (closed bar). …”

Simvastatin decreases eNOS expression. by Mohammed Sabri (355717)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

Que decreases the number of infiltrating T cells in spinal cord. by Feng Mei (143817)

“…Quantification of the staining is depicted in the bar graphs (<b>D and H</b>). Scale bar <b>A–G</b> = 0.5 mm, <b>F’</b> = 50 µm.</p>…”

Trehalose decreased PAN-induced apoptosis in human podocytes. by Yu-Lin Kang (663806)

“…<p>Podocyte were treated with PAN (30 µg/ml) or/and Trehalose (50 mM) for 48 h. (<b>A</b>) Trehalose induced autophagy in PAN-treated human podocytes. …”

Development of a cAMP sensor with decreased pH sensitivity. by Katy L. Everett (461878)